SCHEMBL8280

SCHEMBL8280

BrCC1CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8544495 1.00
SCHEMBL11614918 1.00
SCHEMBL241360 0.92
SCHEMBL25541845 0.85
SCHEMBL167253 0.85
SCHEMBL27036740 0.85
SCHEMBL28259630 0.82
SCHEMBL2197276 0.79
SCHEMBL30688061 0.79
SCHEMBL2002222 0.77 EPHX1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090284-A1 ELECTROLYTE COMPRISING SOLVENT WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-05-01 WO claimed
CN-118431475-A Carbon-based positive electrode material, preparation method thereof and double-ion battery 中国科学院深圳先进技术研究院 2024-08-02 CN claimed
JP-2006517606-A 2006-07-27 JP claimed
EP-1594929-A4 HIGH CONDUCTIVITY INKS WITH LOW MINIMUM CURING TEMPERATURES PARELEC INC (US) 2006-03-22 EP claimed
EP-1594929-A2 HIGH CONDUCTIVITY INKS WITH LOW MINIMUM CURING TEMPERATURES Parelec, Inc. (US) 2005-11-16 EP claimed
US-20040178391-A1 High conductivity inks with low minimum curing temperatures PARELEC INC. 2004-09-16 US claimed
WO-2004067647-A2 HIGH CONDUCTIVITY INKS WITH LOW MINIMUM CURING TEMPERATURES PARELEC INC. (US) 2004-08-12 WO claimed
JP-62114982-A None JP disclosed
US-12637468-B2 Substituted [1,2,4]triazolo[4,3-b]pyridazines as GABAA receptor modulators Shanghai Simr Biotechnology Co., Ltd. (CN) 2026-05-26 US disclosed
EP-4737443-A1 SALT-INDUCIBLE KINASE INHIBITORY COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Tanabe Pharma Corporation (JP) 2026-05-06 EP disclosed
US-20260116881-A1 KIF MODULATOR COMPOUNDS AND METHODS OF USE IAMBIC THERAPEUTICS INC (US) 2026-04-30 US disclosed
US-20260070932-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON INC (US) 2026-03-12 US disclosed
EP-4053108-B1 COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF WUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD (CN) 2026-03-11 EP disclosed
US-4146717-A NITROQUINAZOLINONE COMPOUNDS HAVING ANTIVIRAL PROPERTIES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-03-27 US disclosed
US-4128548-A Process for preparing 6,7-benzomorphans ACF CHEMIEFARMA N.V. (NL) 1978-12-05 US disclosed
US-4118561-A ANTIBACTERIAL, SYNERGISTIC, ANTI-CANCER ACTIVITY, ANTI-FOLIC ACID ACTIVITY AMERICAN HOME PRODUCTS CORPORATION (US) 1978-10-03 US disclosed
US-4100288-A N-Tetrahydrofurfuryl-noroxymorphones, their salts, and analgesic compositions and methods employing them BOEHRINGER INGELHEIM GMBH (DE) 1978-07-11 US disclosed
US-4087532-A Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof BOEHRINGER INGELHEIM GMBH (DT) 1978-05-02 US disclosed
US-3982005-A ANALGESICS BOEHRINGER INGELHEIM GMBH (DT) 1976-09-21 US disclosed
US-3959300-A Novel indolobenzazepine derivatives, useful as tranquilizers ENDO LABORATORIES, INC. (US) 1976-05-25 US disclosed